165 related articles for article (PubMed ID: 26896646)
1. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.
Prado S; Beltrán M; Coiras M; Bedoya LM; Alcamí J; Gallego J
Biochem Pharmacol; 2016 May; 107():14-28. PubMed ID: 26896646
[TBL] [Abstract][Full Text] [Related]
2. A small-molecule inhibitor of HIV-1 Rev function detected by a diversity screen based on RRE-Rev interference.
Prado S; Beltrán M; Moreno Á; Bedoya LM; Alcamí J; Gallego J
Biochem Pharmacol; 2018 Oct; 156():68-77. PubMed ID: 30071201
[TBL] [Abstract][Full Text] [Related]
3. An anti-apoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization.
Modem S; Reddy TR
J Cell Physiol; 2008 Jan; 214(1):14-9. PubMed ID: 17929250
[TBL] [Abstract][Full Text] [Related]
4. RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev-Rev response element complex.
Jayaraman B; Crosby DC; Homer C; Ribeiro I; Mavor D; Frankel AD
Elife; 2014 Dec; 3():e04120. PubMed ID: 25486594
[TBL] [Abstract][Full Text] [Related]
5. Identification of small molecule modulators of HIV-1 Tat and Rev protein accumulation.
Balachandran A; Wong R; Stoilov P; Pan S; Blencowe B; Cheung P; Harrigan PR; Cochrane A
Retrovirology; 2017 Jan; 14(1):7. PubMed ID: 28122580
[TBL] [Abstract][Full Text] [Related]
6. RNA helicase MOV10 functions as a co-factor of HIV-1 Rev to facilitate Rev/RRE-dependent nuclear export of viral mRNAs.
Huang F; Zhang J; Zhang Y; Geng G; Liang J; Li Y; Chen J; Liu C; Zhang H
Virology; 2015 Dec; 486():15-26. PubMed ID: 26379090
[TBL] [Abstract][Full Text] [Related]
7. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
8. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
Najera I; Krieg M; Karn J
J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
[TBL] [Abstract][Full Text] [Related]
9. Cooperative dimerization of a stably folded protein directed by a flexible RNA in the assembly of the HIV Rev dimer-RRE stem II complex.
Tanamura S; Terakado H; Harada K
J Mol Recognit; 2016 May; 29(5):199-209. PubMed ID: 26620599
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
11. [HIV-1 Rev and related inhibitors].
Cao Y; Liu XY
Yao Xue Xue Bao; 2007 Apr; 42(4):347-51. PubMed ID: 17633198
[TBL] [Abstract][Full Text] [Related]
12. [Establishment and application of a screening anti-HIV-1 drug model targeted nuclear trafficking of virus RNA].
Liu ZL; Li XY; Zhang Q; Jia PP; Yang L; Wei XL; Jiang JD; Cen S
Yao Xue Xue Bao; 2010 Feb; 45(2):257-62. PubMed ID: 21351437
[TBL] [Abstract][Full Text] [Related]
13. Structure of an RNA Aptamer that Can Inhibit HIV-1 by Blocking Rev-Cognate RNA (RRE) Binding and Rev-Rev Association.
Dearborn AD; Eren E; Watts NR; Palmer IW; Kaufman JD; Steven AC; Wingfield PT
Structure; 2018 Sep; 26(9):1187-1195.e4. PubMed ID: 30017564
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds.
Zapp ML; Young DW; Kumar A; Singh R; Boykin DW; Wilson WD; Green MR
Bioorg Med Chem; 1997 Jun; 5(6):1149-55. PubMed ID: 9222509
[TBL] [Abstract][Full Text] [Related]
15. Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function.
Wong RW; Balachandran A; Haaland M; Stoilov P; Cochrane A
Nucleic Acids Res; 2013 Nov; 41(20):9471-83. PubMed ID: 23945945
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-based methods for evaluating the RNA affinity and specificity of HIV-1 Rev-RRE inhibitors.
Luedtke NW; Tor Y
Biopolymers; 2003 Sep; 70(1):103-19. PubMed ID: 12925996
[TBL] [Abstract][Full Text] [Related]
17. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar Localization of HIV-1 Rev Is Required, Yet Insufficient for Production of Infectious Viral Particles.
Arizala JAC; Takahashi M; Burnett JC; Ouellet DL; Li H; Rossi JJ
AIDS Res Hum Retroviruses; 2018 Nov; 34(11):961-981. PubMed ID: 29804468
[TBL] [Abstract][Full Text] [Related]
20. Rev-ing up post-transcriptional HIV-1 RNA expression.
Yedavalli VS; Jeang KT
RNA Biol; 2011; 8(2):195-9. PubMed ID: 21358275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]